Urinary Incontinence Management

Introduction

Urinary incontinence affects approximately 51% of women, with a prevalence that increases with age, as reported by the American College of Internal Medicine 1
Factors such as obesity, vaginal childbirth, smoking, caffeine consumption, diabetes, depression, and constipation increase the risk of urinary tract disorders 1

A detailed medical history, including characterization of symptoms, history of recurrent urinary tract infections, and risk factors, is essential for diagnosis 2
Urine analysis and culture can help exclude active urinary tract infection 2
Measurement of post-void residual urine can help evaluate bladder emptying 2
Imaging studies, such as those recommended by the American College of Radiology, may be indicated in certain cases, including recurrent cystitis, persistent bacteriuria, and hematuria 2
Cystourethroscopy is recommended to assess for urethral and bladder pathology in cases requiring surgical intervention, and urodynamic testing may be considered to differentiate between sphincter dysfunction and bladder dysfunction, as stated by the American Urological Association 3

Pelvic floor muscle exercises, such as Kegel exercises, are recommended as the first-line treatment for stress urinary incontinence, reducing incontinence episodes by at least 50%, according to the American College of Physicians and European Association of Urology 4, 5
Supervised pelvic floor muscle training (PFMT) for 8-12 weeks shows superior outcomes compared to unsupervised or leaflet-based care, and is most effective for stress urinary incontinence but can benefit all types, as noted by the American College of Physicians and European Association of Urology 4, 5
Vaginal estrogen formulations have been shown to improve continence and stress UI in women with urinary incontinence 4
Transdermal estrogen patches can worsen UI in women with urinary incontinence 4
Systemic pharmacologic therapy is not recommended for stress UI (strong recommendation, low-quality evidence) 4
Antimuscarinic medications, such as darifenacin, fesoterodine, oxybutynin, solifenacin, tolterodine, and trospium, can be used to treat incontinence, with oxybutynin acting by relaxing bladder smooth muscle and inhibiting involuntary contractions, as recommended by the American Urological Association 6
Beta-3 adrenergic agonists, such as mirabegron, can be used as an alternative with fewer anticholinergic side effects, as stated by the European Association of Urology 6

For women with mixed UI (stress + urgency), PFMT combined with bladder training is strongly recommended (moderate-quality evidence) 4
Bladder training alone can significantly improve urge incontinence, and the combination of bladder training and PFMT is particularly effective for mixed incontinence, with a relative risk of 3.8, according to the American College of Physicians and American Urological Association 4, 6
Weight loss is recommended for obese women, with a strong recommendation and moderate-quality evidence, as noted by the American College of Obstetricians and Gynecologists 4, 1
Fluid management strategies, including a 25% reduction in fluid intake if excessive, reducing caffeine consumption, and avoiding excessive fluids at night, can help alleviate symptoms, as recommended by the American Urological Association 6
Exercise is also recommended to alleviate symptoms of urogenital atrophy and stress urinary incontinence, as noted by the American College of Obstetricians and Gynecologists 4, 1

7, 8, 9

Autologous fascia pubovaginal sling has an 85-92% success rate with 3-15 years follow-up and is an alternative for patients concerned about synthetic mesh, as noted by the American Urological Association 7
Burch colposuspension is an effective alternative, especially for patients undergoing concomitant abdominal-pelvic surgery, with a retention rate of 8% (de novo urge incontinence), according to the American Urological Association 7, 8
Artificial urinary sphincter (AUS) is recommended as a first-line option for severe incontinence or history of radiation therapy, and male slings are an option for moderate incontinence with appropriate counseling, as stated by the American Urological Association 3
Continence pessaries or vaginal inserts may be considered as a treatment option for patients with stress urinary incontinence, as recommended by the American Urological Association 5, 7

Regular long-term follow-up is essential as recurrence can occur even after successful treatment, and a comprehensive symptom evaluation should be performed to determine the type of incontinence and assess the impact on quality of life, using validated questionnaires such as the Bristol Female Lower Urinary Tract Symptoms, as suggested by the International Continence Society 5, 7, 10
Annual screening for urinary incontinence is recommended for women of all ages, assessing the impact of symptoms on daily activities and quality of life, and evaluating and treating urinary tract infections promptly, as they can worsen odor and incontinence, is recommended by the American College of Obstetricians and Gynecologists and American Urological Association 1, 4, 11